Patent details

EP2262505 Title: SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SOLID

Basic Information

Publication number:
EP2262505
PCT Application Number:
PCT/US/2009/001608
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP097189518
PCT Publication Number:
WO/2009/114181
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SOLID
French Title of Invention:
SOLIDE DE GAMMA-CARBOLINES FUSIONNÉES À HÉTÉROCYCLES SUBSTITUÉS
German Title of Invention:
SUBSTITUIERTE HETEROZYKLUS-KONDENSIERTE GAMMA-CARBOLIN-FESTSTOFFE
SPC Number:

Dates

Filing date:
12/03/2009
Grant date:
10/09/2014
EP Publication Date:
10/09/2014
PCT Publication Date:
17/09/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/12/2010
EP B1 Publication Date:
10/09/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/03/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/03/2009
 
 

Name:
Intra-Cellular Therapies Inc.
Address:
3960 Broadway, New York, NY 10032, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
26/11/2014
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
WENNOGLE Lawrence, P.
Address:
United States (US)

2

Name:
TOMESCH John
Address:
United States (US)

Priority

Priority Number:
36069 P
Priority Date:
12/03/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/55;

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2026
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56